6.78
price down icon0.22%   -0.00
after-market Dopo l'orario di chiusura: 6.77 -0.01 -0.15%
loading
Precedente Chiudi:
$6.78
Aprire:
$6.78
Volume 24 ore:
630.15K
Relative Volume:
0.32
Capitalizzazione di mercato:
$2.51B
Reddito:
$9.47B
Utile/perdita netta:
$-178.00M
Rapporto P/E:
-14.13
EPS:
-0.48
Flusso di cassa netto:
$1.01B
1 W Prestazione:
+7.21%
1M Prestazione:
+6.03%
6M Prestazione:
-12.37%
1 anno Prestazione:
+15.05%
Intervallo 1D:
Value
$6.63
$6.84
Intervallo di 1 settimana:
Value
$6.29
$6.895
Portata 52W:
Value
$4.25
$9.85

Bausch Health Companies Inc Stock (BHC) Company Profile

Name
Nome
Bausch Health Companies Inc
Name
Telefono
514-744-6792
Name
Indirizzo
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Name
Dipendente
20,700
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
BHC's Discussions on Twitter

Confronta BHC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
BHC
Bausch Health Companies Inc
6.78 2.46B 9.47B -178.00M 1.01B -0.48
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
152.12 68.32B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.48 46.55B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.875 43.80B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.55 19.01B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
304.50 13.79B 2.99B 1.21B 1.13B 25.06

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-02 Downgrade Piper Sandler Neutral → Underweight
2024-07-10 Iniziato Raymond James Mkt Perform
2023-09-20 Aggiornamento Jefferies Hold → Buy
2023-06-16 Downgrade TD Cowen Outperform → Market Perform
2022-07-29 Downgrade RBC Capital Mkts Outperform → Sector Perform
2022-07-29 Downgrade Truist Buy → Hold
2022-07-28 Downgrade JP Morgan Overweight → Neutral
2022-06-13 Ripresa JP Morgan Overweight
2021-03-24 Downgrade BofA Securities Neutral → Underperform
2021-02-17 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2021-01-22 Downgrade Piper Sandler Overweight → Neutral
2020-09-17 Aggiornamento BofA Securities Underperform → Neutral
2020-08-24 Reiterato H.C. Wainwright Buy
2020-06-17 Reiterato H.C. Wainwright Buy
2020-04-24 Iniziato Citigroup Buy
2020-04-02 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-01-29 Downgrade Wolfe Research Outperform → Peer Perform
2020-01-22 Aggiornamento Wells Fargo Underweight → Equal Weight
2019-12-12 Aggiornamento JP Morgan Neutral → Overweight
2019-12-02 Iniziato Goldman Neutral
2019-10-25 Iniziato Cowen Outperform
2019-09-12 Iniziato Guggenheim Buy
2019-08-15 Aggiornamento TD Securities Hold → Buy
2019-07-19 Iniziato Wolfe Research Outperform
2019-06-11 Ripresa Barclays Overweight
2019-05-13 Aggiornamento JP Morgan Underweight → Neutral
2019-03-20 Iniziato SunTrust Buy
2019-01-02 Aggiornamento Piper Jaffray Neutral → Overweight
2018-11-05 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2018-09-13 Aggiornamento Piper Jaffray Underweight → Neutral
Mostra tutto

Bausch Health Companies Inc Borsa (BHC) Ultime notizie

pulisher
04:16 AM

Bausch Health Companies Inc. Stock Analysis and ForecastTremendous financial leverage - PrintWeekIndia

04:16 AM
pulisher
Jul 24, 2025

Is Bausch Health Companies Inc. stock a good hedge against inflationExplosive wealth accumulation - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Bausch Health adds two pharmaceutical industry veterans to board By Investing.com - Investing.com South Africa

Jul 24, 2025
pulisher
Jul 24, 2025

Bausch Health Announces the Appointment of Two New Members to Its Board of Directors - The Joplin Globe

Jul 24, 2025
pulisher
Jul 24, 2025

Bausch Health Expands Leadership: Ex-Viatris CEO and Bristol Myers Legal Chief Join Board in Strategic Move - Stock Titan

Jul 24, 2025
pulisher
Jul 23, 2025

Is Bausch Health Companies Inc. a good long term investmentFast-track wealth growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Hyperammonemia Market Trends 2025: Growth Drivers & Forecast | - openPR.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Bausch Health Companies Inc. stock pricePhenomenal wealth increase - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

IP Atty's FCA Suit Against Valeant Over Apriso Tossed Again - Law360

Jul 22, 2025
pulisher
Jul 22, 2025

SANDRIDGE ENERGY, INC. ANNOUNCES APPOINTMENT OF BRETT ICAHN TO THE BOARD OF DIRECTORS - The Malaysian Reserve

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Bausch Health Companies Inc. stockTremendous return on equity - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Brett Icahn Takes Board Seat at SandRidge Energy: Major Strategic Move for Oil Producer - Stock Titan

Jul 22, 2025
pulisher
Jul 19, 2025

Best Stock to Buy Right Now: Bausch Health vs Canopy Growth? - MSN

Jul 19, 2025
pulisher
Jul 15, 2025

Bausch Health Faces Patent Drama And Policy Questions This Quarter - Finimize

Jul 15, 2025
pulisher
Jul 15, 2025

Bausch Health's Xifaxan Patent Clarity, Policy Commentary in Focus for Q2, RBC Says - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

In the Wake of Bausch Health Companies Inc.'s (NYSE:BHC) Latest US$196m Market Cap Drop, Institutional Owners May Be Forced to Take Severe Actions - 富途牛牛

Jul 15, 2025
pulisher
Jul 15, 2025

In the wake of Bausch Health Companies Inc.'s (NYSE:BHC) latest US$196m market cap drop, institutional owners may be forced to take severe actions - simplywall.st

Jul 15, 2025
pulisher
Jul 15, 2025

Amblyopia Market Growth Expected to See Next Level with Novartis - openPR.com

Jul 15, 2025
pulisher
Jul 12, 2025

Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel - Yahoo Finance

Jul 12, 2025
pulisher
Jul 11, 2025

Icahn Enterprises shares rise 5.72% intraday after Bausch Health appoints new Chief Accounting Officer. - AInvest

Jul 11, 2025
pulisher
Jul 10, 2025

Bausch Health's Strategic Leadership Shift: Steven Lee's Expertise Could Propel Valuation Growth Amid Transformation - AInvest

Jul 10, 2025
pulisher
Jul 10, 2025

First-Ever Triple-Combination Acne Treatment CABTREO Expands Access Across Canadian Health Programs - Stock Titan

Jul 10, 2025
pulisher
Jul 10, 2025

Bausch Health Names Steven Lee Chief Accounting Officer - MarketScreener

Jul 10, 2025
pulisher
Jul 10, 2025

Bausch Health Appoints New Chief Accounting Officer - MarketScreener

Jul 10, 2025
pulisher
Jul 10, 2025

Bausch Health Strengthens Finance Team: M&A Expert Steven Lee Takes Chief Accounting Officer Role - Stock Titan

Jul 10, 2025
pulisher
Jul 09, 2025

Groundbreaking Triple-Combination Acne Treatment Expands Access Across Canadian Healthcare System - Stock Titan

Jul 09, 2025
pulisher
Jul 07, 2025

Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence - New Castle News

Jul 07, 2025
pulisher
Jul 07, 2025

First FDA-Approved Drug Xifaxan Unveils Powerful Patient Stories in New Hepatic Encephalopathy Campaign - Stock Titan

Jul 07, 2025
pulisher
Jul 03, 2025

SHAREHOLDER ALERT: Potential Recovery for Bausch Health Companies Inc. (BHC) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

Jul 03, 2025
pulisher
Jul 03, 2025

Bausch Health Companies Reaches Analyst Target Price - Nasdaq

Jul 03, 2025
pulisher
Jul 03, 2025

August 22nd Options Now Available For Bausch Health Companies (BHC) - Nasdaq

Jul 03, 2025
pulisher
Jul 02, 2025

Stocks In Play: Bausch Health Companies - Barchart.com

Jul 02, 2025
pulisher
Jul 02, 2025

Bausch Health to Announce Second Quarter 2025 Results on July 30 - Corsicana Daily Sun

Jul 02, 2025

Bausch Health Companies Inc Azioni (BHC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$72.91
price up icon 2.79%
$14.93
price up icon 1.60%
$9.415
price up icon 0.59%
drug_manufacturers_specialty_generic RDY
$14.66
price down icon 0.31%
$132.16
price up icon 0.38%
$304.50
price down icon 0.57%
Capitalizzazione:     |  Volume (24 ore):